For many people, injections are the most effective way to manage a deficiency, particularly where absorption from tablets is limited
[7] [14] Participants receiving higher doses of retatrutide (particularly 8 mg and 12 mg weekly) experienced mean increases in heart rate of approximately 5 to 7 beats per minute (bpm) above baseline, based on data reported in the 2023 NEJM Phase 2 publications
Furthermore, a prespecified subgroup analysis of HF individuals from the SELECT trial evaluating the effects of semaglutide on cardiovascular outcomes in people with overweight or obesity, which included 2,273 HFpEF and 1,347 HFrEF patients, showed that the therapy was associated with a reduction in the HF composite outcome (cardiovascular death or HF hospitalisation/emergency visit) across LVEF, suggesting that GLP-1 RAs may improve outcomes at least in obese HF patients regardless of diabetes status
With ongoing research expanding DSIPs potential applications, individuals interested in exploring its benefits are encouraged to consult with Eternity Health Partners for expert guidance and customized treatment plans